This work has been retracted.
Retraction: ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway
Year: 2025
Type: retraction
Abstract: Article Title: Retraction: ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway Author: Frontiers Editorial Office* Frontiers Media SA, Lausanne, Switzerland Content: A Retraction of the Original Research Article:ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway By Ding Z, Yu F, Sun Y, Jiao N, Shi L, Wan J and Liu Q (2022) ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway. Front. Pediatr. 9:708555. doi: 10.3389/fped.2021.708555The journal retracts the 16 February 2022 article cited above.Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.This retraction was approved by the Chief Editors of Frontiers in Pediatrics and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
Source: Frontiers in Pediatrics
Author: Frontiers Editorial Office
Institution: Consejo Superior de Investigaciones Científicas
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W4411344356